CPT code 85415 represents a laboratory assay for a fibrinolytic factor or inhibitor related to plasminogen activation. This test assesses key regulators of plasmin generation and fibrinolysis, informing diagnosis and management of bleeding and thrombotic conditions. The code is relevant across inpatient and outpatient laboratory settings and is commonly ordered when evaluating unexplained bleeding, suspected hyperfibrinolysis, or monitoring certain therapeutic interventions.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how CPT code 85415 is defined clinically, typical sites of service, and common contexts for ordering the test. The publication summarizes national coding and billing considerations, reimbursement benchmarks where available, and clinical implications for lab operations and provider documentation.

This summary is intended to provide clinicians, laboratory managers, and billing professionals with a clear, national-level reference for CPT code 85415, including what the code represents, why it matters in patient care, and the main topics covered in the full publication: coding guidance, payer coverage patterns, and clinical context for test utilization. Data not available in the input will be noted where applicable.